166 related articles for article (PubMed ID: 15595689)
41. Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome.
Ward JF; Slezak JM; Blute ML; Bergstralh EJ; Zincke H
BJU Int; 2005 Apr; 95(6):751-6. PubMed ID: 15794776
[TBL] [Abstract][Full Text] [Related]
42. Palliative transurethral resection of the prostate: functional outcome and impact on survival.
Marszalek M; Ponholzer A; Rauchenwald M; Madersbacher S
BJU Int; 2007 Jan; 99(1):56-9. PubMed ID: 17034496
[TBL] [Abstract][Full Text] [Related]
43. [Clinical study of prostate specific antigen failure after radical prostatectomy for prostate cancer: a single center experience].
Taue R; Takahashi M; Fukawa T; Koizumi T; Nakanishi R; Yamaguchi K; Yamamoto Y; Nakatsuji H; Kishimoto T; Izaki H; Oka N; Fukumori T; Kanayama HO
Hinyokika Kiyo; 2009 Jan; 55(1):1-4. PubMed ID: 19227203
[TBL] [Abstract][Full Text] [Related]
44. Laparoscopic radical prostatectomy: the value of intraoperative frozen sections.
Dillenburg W; Poulakis V; Witzsch U; de Vries R; Skriapas K; Altmansberger HM; Becht E
Eur Urol; 2005 Oct; 48(4):614-21. PubMed ID: 16054291
[TBL] [Abstract][Full Text] [Related]
45. High Incidence of Incidental Prostate Cancer in Transurethral Resection of Prostate Specimens in China. The Value of Pathologic Review.
Lin J; Yu X; Yang X; Jin J; Zhou L; Liu L; Su J; Li Y; Shang M
Anal Quant Cytopathol Histpathol; 2016 Feb; 38(1):31-7. PubMed ID: 27363064
[TBL] [Abstract][Full Text] [Related]
46. Surgical outcomes for men undergoing laparoscopic radical prostatectomy after transurethral resection of the prostate.
Jaffe J; Stakhovsky O; Cathelineau X; Barret E; Vallancien G; Rozet F
J Urol; 2007 Aug; 178(2):483-7; discussion 487. PubMed ID: 17561162
[TBL] [Abstract][Full Text] [Related]
47. Nerve-sparing radical retropubic prostatectomy in patients previously submitted to holmium laser enucleation of the prostate for bladder outlet obstruction due to benign prostatic enlargement.
Suardi N; Scattoni V; Briganti A; Salonia A; Naspro R; Gallina A; Cestari A; Colombo R; Karakiewicz PI; Guazzoni G; Rigatti P; Montorsi F
Eur Urol; 2008 Jun; 53(6):1180-5. PubMed ID: 17659829
[TBL] [Abstract][Full Text] [Related]
48. Radical prostatectomy for clinical stage T3a disease.
Freedland SJ; Partin AW; Humphreys EB; Mangold LA; Walsh PC
Cancer; 2007 Apr; 109(7):1273-8. PubMed ID: 17315165
[TBL] [Abstract][Full Text] [Related]
49. Prostate-specific antigen kinetics in screen-detected prostate cancer in Japan.
Takechi H; Ito K; Yamamoto T; Miyakubo M; Ohi M; Suzuki K
Urology; 2008 Nov; 72(5):1111-5. PubMed ID: 18342926
[TBL] [Abstract][Full Text] [Related]
50. Lymphovascular invasion is an independent predictor of prostate-specific antigen failure after radical prostatectomy in patients with pT3aN0 prostate cancer.
Yamamoto S; Kawakami S; Yonese J; Fujii Y; Ohkubo Y; Suyama T; Komai Y; Kijima T; Ishikawa Y; Fukui I
Int J Urol; 2008 Oct; 15(10):895-9. PubMed ID: 18721204
[TBL] [Abstract][Full Text] [Related]
51. Clinical significance of benign glands at surgical margins in robotic radical prostatectomy specimens.
Kohl SK; Balaji KC; Smith LM; Wilson NP; Johansson SL; Sterrett SP; Abrahams NA
Urology; 2007 Jun; 69(6):1112-6. PubMed ID: 17572197
[TBL] [Abstract][Full Text] [Related]
52. Effect of neoadjuvant epirubicin and total androgen blockade on complete pathological response in patients with clinical stage T3/T4 prostate cancer.
Francini G; Paolelli L; Francini E; Pascucci A; Manganelli A; Salvestrini F; Petrioli R
Eur J Surg Oncol; 2008 Feb; 34(2):216-21. PubMed ID: 17502132
[TBL] [Abstract][Full Text] [Related]
53. Incidental carcinoma of the prostate: histopathology and natural history.
Nemoto R; Harada M; Uchida K; Koiso K; Abe R; Kato T
Jpn J Clin Oncol; 1985 Dec; 15(4):619-23. PubMed ID: 2419598
[TBL] [Abstract][Full Text] [Related]
54. The role of radical prostatectomy in patients with clinically localized prostate cancer and a prostate-specific antigen level >20 ng/ml.
Bastide C; Kuefer R; Loeffler M; de Petriconi R; Gschwend J; Hautmann R
Prostate Cancer Prostatic Dis; 2006; 9(3):239-44. PubMed ID: 16832384
[TBL] [Abstract][Full Text] [Related]
55. Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005.
Adolfsson J; Garmo H; Varenhorst E; Ahlgren G; Ahlstrand C; Andrén O; Bill-Axelson A; Bratt O; Damber JE; Hellström K; Hellström M; Holmberg E; Holmberg L; Hugosson J; Johansson JE; Petterson B; Törnblom M; Widmark A; Stattin P
Scand J Urol Nephrol; 2007; 41(6):456-77. PubMed ID: 17934985
[TBL] [Abstract][Full Text] [Related]
56. TP53 mutation in prostate needle biopsies--comparison with patients follow-up.
Ecke TH; Schlechte HH; Hübsch A; Lenk SV; Schiemenz K; Rudolph BD; Miller K
Anticancer Res; 2007; 27(6B):4143-8. PubMed ID: 18225585
[TBL] [Abstract][Full Text] [Related]
57. [Transurethral resection of prostate weighing over 100G].
Nakajima H; Mori K; Ohnishi S; Kato S; Tanda H
Hinyokika Kiyo; 1988 Dec; 34(12):2121-7. PubMed ID: 2467540
[TBL] [Abstract][Full Text] [Related]
58. [Subtotal transurethral prostatectomy in the treatment of patients with prostatic cancer].
Mazo EB; Chepurov AK; Zoria OV
Urologiia; 2005; (6):6-10. PubMed ID: 16419471
[TBL] [Abstract][Full Text] [Related]
59. Multigene methylation analysis for detection and staging of prostate cancer.
Enokida H; Shiina H; Urakami S; Igawa M; Ogishima T; Li LC; Kawahara M; Nakagawa M; Kane CJ; Carroll PR; Dahiya R
Clin Cancer Res; 2005 Sep; 11(18):6582-8. PubMed ID: 16166436
[TBL] [Abstract][Full Text] [Related]
60. [Transurethral prostatectomy with the bipolar plasmakinetic technique for benign prostate hyperplasia: a report of 712 cases].
Che XY; Song XS; Wu DJ; Wang FP; Wang QF; Wang JB
Zhonghua Nan Ke Xue; 2009 May; 15(5):449-51. PubMed ID: 19514560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]